逆行入路血运重建患者主要不良结局的回顾性分析
该回顾性分析纳入2014至2022年两家机构的573例下肢腔内斑块旋切术,比较传统顺行入路与逆行入路患者的主要不良肢体事件(MALE)及入路部位并发症。逆行入路患者术前病情更重(既往手术史比例更高、术前通畅胫动脉数量更少),但多因素分析显示其MALE风险与入路并发症风险均未显著高于顺行入路患者。
要点
- 573例腔内血运重建中90例(15.7%)为逆行入路,其中70例成功逆行通过病变。
- 逆行入路患者既往手术史比例更高(37.9% vs 58.6%,P<0.001),术前通畅胫动脉数量更少(1.8 vs 1.1,P<0.001)。
核心结论
- 尽管术前条件更差,逆行入路患者的主要不良肢体事件和入路部位并发症风险并未高于顺行入路患者。
研究设计与样本
- 回顾性分析,纳入2014至2022年两家机构的573例下肢腔内斑块旋切术。
- 逆行入路定义为经胫前动脉、胫后动脉、腓动脉或足背动脉进行腔内入路。
- 主要不良肢体事件定义为开放动脉旁路手术、小截肢或大截肢。
- 采用多因素logistic回归计算MALE的比值比,并控制人口学特征和合并症。
- 采用Cox比例风险分析分析时间-事件数据,并控制人口学特征和合并症。
主要发现
- 573例腔内血运重建中90例(15.7%)为逆行入路血运重建,其中70例成功经逆行途径通过病变。
- 需要逆行入路的患者更可能有既往手术干预史(37.9% vs 58.6%,P<0.001),且术前通畅胫动脉平均数量更少(1.8 vs 1.1,P<0.001)。
- 逆行入路患者入路部位并发症(血肿、入路部位血栓形成、感染或假性动脉瘤)风险未更高(5.6% vs 1.6%,P=0.6)。
临床怎么用
- 对于顺行方向无法通过闭塞病变的患者,逆行入路可能与传统顺行入路同样安全有效(作者结论)。
局限性
- 逆行入路队列较小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lower extremity endovascular revascularizations in patients with peripheral artery disease traditionally utilize contralateral femoral artery access. However, retrograde access (RA) from a tibial and/or pedal vessel is increasingly used as an access point to facilitate crossing a lesion. This study aims to compare outcomes between traditional antegrade access (AA) and RA patients to determine if RA is associated with greater risk of negative outcomes. METHODS: This retrospective analysis included 573 endovascular atherectomies from 2 institutions from 2014 to 2022. RA patients were defined as patients who underwent endovascular access from the anterior tibial, posterior tibial, peroneal, or dorsalis pedis artery. Major adverse limb event (MALE) was defined as open arterial bypass surgery, minor amputation, or major amputation. Multivariate logistic regression models calculated the odds ratio of MALE and controlled for demographics and comorbidities. Cox proportional hazard analysis was performed to analyze time-to-event data and controlled for demographics and comorbidities. RESULTS: Among the 573 endovascular revascularizations, 90 (15.7%) were RA revascularizations, 70 of which were successful crossing lesions via a retrograde approach. Patients requiring RA were more likely to have a previous history of surgical interventions (37.9% vs. 58.6%, P < 0.001) and a lower average number of preoperative patent tibial run-off vessels (1.8 vs. 1.1, P < 0.001). In this analysis, patients undergoing RA were not at greater risk of access site complications defined as hematomas, access site thrombosis, infection, or pseudoaneurysm (5.6% vs. 1.6%, P = 0.6). On multivariate logistic regression, RA patients were not at higher odds of MALE (odds ratio = 0.80, confidence interval (CI) = [0.32-1.94], P = 0.6). Cox proportional hazard analysis showed that RA patients did not have a greater hazard ratio for MALE (hazard ratio = 0.72, CI = [0.35-1.49], P = 0.4). CONCLUSION: Despite worse preoperative conditions, RA patients were not at greater risk of MALE or access site complications than AA patients. The lack of difference in longitudinal outcomes, albeit with a smaller RA cohort, indicates that RA may be as safe and effective as AA for patients whose occlusions cannot be crossed from the antegrade direction.
引用
- Min A, Daidone M, Lopez S, et al. Retrospective Analysis of Major Adverse Outcomes of Retrograde Access Revascularization Patients. Ann Vasc Surg. 2025. PMID: 40349839. doi:10.1016/j.avsg.2025.04.136
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。